End Stage Renal Disease on Dialysis — Temperature and Bicarbonate: Hemodynamic Effects During Dialysis
Citation(s)
Ayoub A, Finlayson M Effect of cool temperature dialysate on the quality and patients' perception of haemodialysis. Nephrol Dial Transplant. 2004 Jan;19(1):190-4.
Daugirdas JT Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol. 1993 Nov;4(5):1205-13.
Elsharkawy MM, Youssef AM, Zayoon MY Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates. Hemodial Int. 2006 Oct;10 Suppl 2:S16-23.
Gabutti L, Bianchi G, Soldini D, Marone C, Burnier M Haemodynamic consequences of changing bicarbonate and calcium concentrations in haemodialysis fluids. Nephrol Dial Transplant. 2009 Mar;24(3):973-81. doi: 10.1093/ndt/gfn541. Epub 2008 Oct 8.
Karamperis N, Sloth E, Jensen JD The hemodynamic effect of calcium ion concentration in the infusate during predilution hemofiltration in chronic renal failure. Am J Kidney Dis. 2005 Sep;46(3):470-80.
Kisloukhine VV, Dean DA Validation of a novel ultrasound dilution method to measure cardiac output during hemodialysis. ASAIO J. 1996 Sep-Oct;42(5):M906-7.
Moser M, Kenner T Blood flow and blood volume determinations in aorta and in coronary circulation by density dilution. Basic Res Cardiol. 1988 Nov-Dec;83(6):577-89.
Selby NM, Burton JO, Chesterton LJ, McIntyre CW Dialysis-induced regional left ventricular dysfunction is ameliorated by cooling the dialysate. Clin J Am Soc Nephrol. 2006 Nov;1(6):1216-25. Epub 2006 Oct 11.
Shoji T, Tsubakihara Y, Fujii M, Imai E Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients. Kidney Int. 2004 Sep;66(3):1212-20.
Tsutsui M, Matsuoka N, Ikeda T, Sanjo Y, Kazama T Comparison of a new cardiac output ultrasound dilution method with thermodilution technique in adult patients under general anesthesia. J Cardiothorac Vasc Anesth. 2009 Dec;23(6):835-40. doi: 10.1053/j.jvca.2009.03.007. Epub 2009 May 22.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.